Upgrade to SI Premium - Free Trial

Com-guard.com, Inc. (GUD)

0.00 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Knight Therapeutics Announces Regulatory Submission of GEMTESA® in Canada September 15, 2026 7:30 AM - Globe NewsWire Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Colombia September 1, 2026 6:00 PM - Globe NewsWire Knight Therapeutics Announces Supplemental Regulatory Submission for MINJUVI® (tafasitamab) in Brazil August 27, 2026 6:00 PM - Globe NewsWire Knight Therapeutics Announces Launch of WYNZORA® in Canada August 20, 2026 7:30 AM - Globe NewsWire Knight Therapeutics Reports Second Quarter 2026 Results August 6, 2026 6:30 AM - Globe NewsWire Notice of Knight Therapeutics' Second Quarter 2026 Results Conference Call July 30, 2026 6:30 AM - Globe NewsWire Full Article List